Abstract:Introduction Clinically isolated syndrome describes a first neurological episode that is consistent with acute onset of inflammatory or demylinating syndrome in the central nervous system (CNS). Interestingly, 90% of MS patients manifest themselves as CIS patients during initial clinical visits and more than 80% of CIS patients with MRI lesions will eventually develop MS. Furthermore, 95% of MS patients are oligoclonal immunoglobulin G bands (OCB) positive in CSF (OCB+) in the western countries. Therefore, one could hypothesize that OCB+ CIS patients may be more vulnerable to evolve to MS. In this study, we directly compared the OCB+/CIS patients for structural differences using both diffusion tensor imaging (DTI) parametric maps and tissue density maps. Materials and Methods This is an IRB approved study. T1 weighted (1mm in voxel size) and DTI images (6 different encoding directions and 2mm in voxel size) were collected from10 OCB-(3M, 7F 42.1±14.1 years old) and 11 OCB+ (0M, 11F, 35.3±11.5 years old) CIS patients. All of the images were acquired with a Siemens 3T head only scanner. Written consents were obtained from all subjects prior to image acquisition. Four parameters were evaluated, including fractional anisotropy (FA), mean (MD), axial (AD) and radial diffusivities (MD) from DTI. All of the T1 images were registered towards a pre-segmented template (not a subject from this study) using an elastic registration approach, HAMMER [3]. After registration, a series of pre-defined ROIs in the template space (including frontal, parietal, temporal, occipital white matter, corpus callosum, internal capsules, thalamus and basal ganglia) were mapped towards each individual subject’s original frame to compute the medians of the four DTI parameters (FA, MD, AD and RD) for the t-tests between OCB+/groups. Besides ROI based analysis, we further compared the DTI parametric maps and tissue density maps based upon T1 segmentation between the two groups with a voxel based analysis approach. Results Using ROI analysis, OCB+ group demonstrated significantly decreased FA, increased MD and RD in the corpus callosum, and significantly increased AD within the frontal white matter compared to the OCBgroup (Fig. 1). In voxel based comparisons, significant regions were identified in the medial left frontal lobe with an elevated axial diffusivity in OCB+ patients (indicated with red arrows, top panel, Fig. 2). Additionally, in T1 based tissue density comparisons, OCB+ patients demonstrated two large regions with white matter tissue loss compared to OCBpatients. The two regions included the left splenium of corpus callosum (red arrows, middle panel, Fig. 2) and the right frontal lobe (green arrows, middle panel, Fig. 2). In order to confirm this finding, we further compared the tissue density maps from OCB+ patients with a large group of healthy controls (35 volunteers). Similar regions were observed with the exception that the abnormal volumes were larger and an additional region in left frontal (blue arrow, bottom panel, Fig. 2) was observed for the comparison between OCB+ and controls (bottom panel, Fig. 2). No such white matter tissue loss was observed in OCBpatients when compared with healthy control.

Advanced MRI Features in Relapsing Multiple Sclerosis Patients with and Without CSF Oligoclonal IgG Bands

Comparison of Multiple Sclerosis Patients with and Without Oligoclonal IgG Bands in South China

Cerebrospinal Fluid Oligoclonal Bands in Chinese Patients with Multiple Sclerosis: the Prevalence and Its Association with Clinical Features

Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naïve patients with multiple sclerosis

Structural differences in OCB-/ + patients with clinically isolated syndrome suggestive of MS

The clinical significance of cerebrospinal fluid oligoclonal bands for multiple sclerosis

A study of cerebral spinal fluid oligoclonal bands in neurological diseases.

Analysis of oligocional band, IgG index and IgG synthesis rate in patients with multiple sclerosis

Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis

Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder

Callosal Lesions on Magnetic Resonance Imaging with Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder and Acute Disseminated Encephalomyelitis.

Application of CSF electrophoresis in multiple sclerosis

Characteristics of cerebral blood flow in an Eastern sample of multiple sclerosis patients: A potential quantitative imaging marker associated with disease severity

Brain MRI characteristics in neuromyelitis optica spectrum disorders: A large multi-center retrospective study in China

Structural Covariance in Subcortical Regions in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: an MRI-based Study with Automated Brain Volumetry.

Clinical Significance of Oligoclonal Bands and IgG Index for Multiple Sclerosis

Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement

Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis

[The combined application of oligoclonal bands in cerebrospinal fluid and IgG intrathecal synthesis indicators and biochemical markers in the diagnosis of multiple sclerosis]

Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosis